The University of Texas MD Anderson Cancer Center today was named number one in the nation for cancer care in U.S. News & World Report’s 2023-24 “Best Hospitals” survey. The institution has been one of the nation’s top two hospitals for cancer care since the survey’s inception in 1990.
“At MD Anderson, we remain singularly focused on eliminating cancer,” said Peter WT Pisters, M.D., president of MD Anderson. “We are pleased...
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered loss of metabolic fitness in chimeric antigen...
The University of Texas MD Anderson Cancer Center today announced the expansion of its global oncology efforts in Mozambique and Brazil, including...
The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.
The agreement brings together Nexo’s unique drug discovery platform, which combines...
The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe...
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
A new study led by researchers at The University of Texas MD Anderson Cancer Center provides a deeper understanding of the evolution of the...